Ank Agarwal

Featured in: Favicon

jamanetwork.com Favicon

newsbreak.com Favicon

kevinmd.com

Articles

Why rapid weight loss drugs may not be the health solution they seem [PODCAST]

Dec 4, 2024 | kevinmd.com | Tatum R. Dam |Diana Hla |Aditya Narayan |Ank Agarwal

Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes!Join us in this episode as we talk with health reporter Martha Rosenberg about the complex dynamics behind obesity, junk food advertising, and the surge of new semaglutide-based weight loss drugs. We explore the implications of these drugs on public health, their potential long-term side effects, and the societal and economic impact of prioritizing quick fixes over sustainable health solutions.
Challenges With Relying on Body Fat and Weight Values for Obesity-Reply

Jun 17, 2024 | jamanetwork.com | Aditya Narayan |Ank Agarwal |Fatima Cody Stanford

Challenges With Relying on Body Fat and Weight Values for Obesity—Reply In Reply We express our gratitude to Kahn and Xiao for their thoughtful engagement with our Viewpoint on including fat loss measurements alongside weight as primary outcomes in clinical trials for anti-obesity medications.1 We happily maintain an ongoing dialogue with the medical community regarding the challenges and evolving methodologies in obesity treatment.
Challenges With Relying on Body Fat and Weight Values for Obesity

Jun 17, 2024 | jamanetwork.com | Lu Xiao |Ank Agarwal |Aditya Narayan |Fatima Cody Stanford

Challenges With Relying on Body Fat and Weight Values for Obesity Body Composition in Anti-Obesity Medication Trials Ank A. Agarwal, BA; Aditya Narayan, BS; Fatima Cody Stanford, MD, MPH, MPA, MBA Challenges With Relying on Body Fat and Weight Values for Obesity—Reply Aditya Narayan, BS; Ank A.
Body Composition in Anti-Obesity Medication Trials

Feb 19, 2024 | jamanetwork.com | Ank Agarwal |Aditya Narayan |Fatima Cody Stanford

Body Composition in Anti-Obesity Medication Trials—Beyond Scales Obesity is the world’s most prevalent chronic disease and has increasingly been recognized as a global public health challenge. It has alarming health effects and burdens health care systems globally. From 2013 to 2016, approximately half of US adults undertook weight loss initiatives, reflecting widespread concerns about weight and efforts toward healthier living.
Beyond the headlines: the truth about weight loss drugs [PODCAST]

Jan 6, 2024 | kevinmd.com | Tatum R. Dam |Diana Hla |Aditya Narayan |Ank Agarwal

Subscribe to The Podcast by KevinMD. Catch up on old episodes!We sit down with David Ahn, an endocrinologist. Join us as we delve into the impact of weight-loss drugs, the role of incretin medications, and their potential to reshape our approach to obesity and overall health. David Ahn is an endocrinologist and chief of diabetes services, Hoag Memorial Hospital Presbyterian, Newport Beach, CA.
How to sell your losing stocks to reduce taxes

Dec 6, 2023 | kevinmd.com | Amarish Dave |Christopher Johnson |Allie Poles |Ank Agarwal

Defining tax loss sellingTax loss selling, also known as tax-loss harvesting, is a strategy employed by investors to offset capital gains and reduce their taxable income. This approach involves selling stocks or other securities that have experienced losses to counterbalance capital gains realized throughout the year. By doing so, investors aim to mitigate their tax liability and potentially improve their after-tax returns. Mechanics of tax loss sellingIdentifying losses.
What we have to gain from weight loss drugs

Nov 9, 2023 | kevinmd.com | Tatum R. Dam |Diana Hla |Aditya Narayan |Ank Agarwal

Twenty years ago, the headlines were grim. It was common for studies to warn: “Rising childhood obesity will decrease life expectancy.” In large part, those predictions came true. The rise in obesity – both in children and adults – has correlated to a catastrophic rise in chronic disease that continues to affect life expectancy, cost of care, and quality of life.
It is time for the FDA to re-evaluate metrics for weight loss drugs

Jul 4, 2023 | kevinmd.com | Diana Hla |Aditya Narayan |Ank Agarwal |Tatum R. Dam

Between 2013 and 2016, 49.1 percent of U.S. adults surveyed had attempted to lose weight within the last 12 months. Weight loss medications have reached the public eye in popular culture and practice. To be considered effective in a clinical trial by the FDA, the drug candidate must demonstrate a statistically significant difference in mean weight loss between the active product and placebo-treated group of at least five percentage points.
The unintended consequences of centralized EHR scheduling

May 15, 2023 | kevinmd.com | Richard Plotzker |Betty Rabinowitz |Amanda Xi |Ank Agarwal

One of the not often discussed challenges of our EHRs may be getting patients to the right medical resource at a time most suitable for their medical condition. Our electronic systems, whether automated by algorithm or assigned to a person given a protocol have become too separated from medical care itself. Our schedulers are no longer ourselves or our secretaries trained in the variability of patient needs, which can then be reflected in physician encounters.